THE IMPACT OF THE COVID19 PANDEMIC ON PATIENTS WITH PERIPHERAL ARTERY DISEASE

John Tanaka; Dennis I. Narcisse; Lin Gu; Antonio Gutiérrez; Ryan D. Schulteis; Rajesh V. Swaminathan; Jennifer A. Rymer; Simon Jones; Sunil V. Rao

doi:10.1016/s0735-1097(23)01245-7

Related publications

Article2019

Impact of left ventricular function on clinical outcomes among patients with coronary artery disease

George C.M. Siontis, Mattia Branca, Patrick W. Serruys, Sigmund Silber, Lorenz Räber, Thomas Pilgrim, Marco Valgimigli, Dik Heg, Stephan Windecker, Lukas Hunziker

European Journal of Preventive Cardiology

Article2014

Risk factors for peripheral artery disease among patients with diabetes in Saudi Arabia

Hasan Alzahrani, Dong Wang, Balkees Abed Bakhotmah, Frank B Hu

Article2019

Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin

John W. Eikelboom, Jackie Bosch, Stuart J. Connolly, Olga Shestakovska, Gilles R. Dagenais, Robert G. Hart, Darryl P. Leong, Martin O’Donnell, Keith A.A. Fox, Deepak L. Bhatt, John A. Cairns, Christoph Tasto, Scott D. Berkowitz, Nancy Cook Bruns, Eva Muehlhofer, Rafael Díaz, Aldo Maggioni, Salim Yusuf

Article2017

Relationship of peripheral and coronary artery disease to cardiovascular events in patients with atrial fibrillation

Daniele Pastori, Pasquale Pignatelli, Angela Sciacqua, Maria Perticone, Francesco Violi, Professor Gregory Lip

Article2021

Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

John W. Eikelboom, Deepak L. Bhatt, Keith A.A. Fox, Jackie Bosch, Stuart J. Connolly, Sonia S. Anand, Álvaro Avezum, Scott D. Berkowitz, Kelley R. Branch, Gilles R. Dagenais, Camilo Félix, Tomasz J. Guzik, Robert G. Hart, Aldo Maggioni, Eva Muehlhofer, Mukul Sharma, Olga Shestakovska, Salim Yusuf